<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="87232">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01757951</url>
  </required_header>
  <id_info>
    <org_study_id>OYSnilkka-RCT4</org_study_id>
    <nct_id>NCT01757951</nct_id>
  </id_info>
  <brief_title>Unimalleolar Versus Bimalleolar Fixation in Bi- or Trimalleolar Ankle Fracture</brief_title>
  <official_title>Unimalleolar Versus Bimalleolar Fixation in Bi- or Trimalleolar Ankle Fracture - A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <authority>Finland: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A one third of all ankle fractures are bi- or trimalleolar. Traditionally these fractures
      are treated by both medial and lateral osteosynthesis, sometimes accompanied by
      osteosynthesis of the posterior malleolus. There is significant evidence that fractures of
      the lateral malleolus can be treated conservatively if the medial side is stable. However,
      there isn't a single study comparing standard bi- or trimalleolar fixation with only medial
      side osteosynthesis and postoperative immobilization with a cast.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Rand-36</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Olerud-Molander Score</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Talocrural joint congruence</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Fracture healing</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>VAS</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Trauma</condition>
  <arm_group>
    <arm_group_label>Unimalleolar Fixation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Talocrural joint is stable after fixation of medial malleolus. Patient is randomized to unimalleolar fixation group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bimalleolar Fixation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Talocrural joint is stable after fixation of medial malleolus. Patient is randomized to bimalleolar fixation group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Talocrural joint is stable after fixation of medial malleolus. Patient is then randomized</intervention_name>
    <arm_group_label>Unimalleolar Fixation</arm_group_label>
    <arm_group_label>Bimalleolar Fixation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Weber B bi- or trimalleolar ankle fracture

          -  Age: 16 years or older

          -  Voluntary

          -  Operated within 7 days of the trauma

        Exclusion Criteria:

          -  Peripheral neuropathy

          -  Pilon fracture

          -  Bilateral ankle fracture

          -  Simultaneous crural fracture

          -  Pathological fracture

          -  Active infection around the ankle

          -  A previous ankle fracture on either side

          -  In trimalleolar fractures over 30% of the joint line is included in the     posterior
             malleolus fragment

          -  Lives outside our hospital district or a foreigner

          -  Co-operation is insufficient
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harri J Pakarinen, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Pohjois-Pohjanmaan sairaanhoitopiiri</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simo S Nortunen, MD</last_name>
    <phone>+35883152011</phone>
    <email>simo.nortunen@ppshp.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Harri J Pakarinen, MD, PhD</last_name>
    <phone>+35883152011</phone>
    <email>harri.pakarinen@ppshp.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <zip>90029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simo S Nortunen, MD</last_name>
      <phone>+35883152011</phone>
      <email>simo.nortunen@ppshp.fi</email>
    </contact>
    <contact_backup>
      <last_name>Harri J Pakarinen, MD, PhD</last_name>
      <phone>+35883152011</phone>
      <email>harri.pakarinen@ppshp.fi</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 21, 2012</lastchanged_date>
  <firstreceived_date>December 21, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oulu</investigator_affiliation>
    <investigator_full_name>Harri Pakarinen</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Ankle</keyword>
  <keyword>Fracture</keyword>
  <keyword>medial malleolus</keyword>
  <keyword>Osteosynthesis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
